Tag: Parliamentary Question

  • Maria Eagle – 2016 Parliamentary Question to the Department for Culture, Media and Sport

    Maria Eagle – 2016 Parliamentary Question to the Department for Culture, Media and Sport

    The below Parliamentary question was asked by Maria Eagle on 2016-03-16.

    To ask the Secretary of State for Culture, Media and Sport, what steps his Department is taking to help arts and cultural organisations apply for funding from the EU’s Creative Europe programme.

    Mr Edward Vaizey

    The Creative Europe Desk UK, which is part-funded by DCMS, raises awareness of the opportunities offered by the EU’s Creative Europe programme; encourages the UK’s creative sectors to engage in the programme through taking part in supported international initiatives and networks‎; and provides advice and support to UK-based applicants of Creative Europe. The Desk is led by the British Council and the BFI with a consortium of partners in the UK (Arts Council England, Creative Scotland, Arts Council of Northern Ireland, Welsh Government).

  • Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

    To ask Her Majesty’s Government for what reason NHS England intends to treat only a specified number of patients in 2016–17, as defined by recently published run rates for operational delivery networks services.

    Lord Prior of Brampton

    The National Institute for Health and Care Excellence (NICE) specifically requires Operational Delivery Networks (ODNs) to prioritise hepatitis C patients on the basis of highest unmet clinical need, as part of a progressive rollout of treatments over the next five years.

    NHS England is funding providers to double the number of patients treated and this number will ensure the National Health Service fully meets in 2016/17 the patient numbers NICE set out for progressive rollout of the treatments at the time it published its guidance.

    NHS England has invested in a Commissioning for Quality and Innovation scheme to incentivise ODNs to meet their agreed rate of roll-out. If their treatment rates deviate from this agreed rate of treatment, they are no longer eligible for these incentives.

    In meeting the obligations of its Mandate, NHS England has set out a planning approach for hepatitis C that delivers access to NICE recommended treatment without disinvestment in other health services.

  • Julian Knight – 2016 Parliamentary Question to the Department for Work and Pensions

    Julian Knight – 2016 Parliamentary Question to the Department for Work and Pensions

    The below Parliamentary question was asked by Julian Knight on 2016-05-04.

    To ask the Secretary of State for Work and Pensions, what plans he has to extend the Pensions Wise service to people (a) between 20 and 40 and (b) between 40 and 50; and if he will make that service available to advise people on whether to invest in a lifetime ISA or under auto enrolment.

    Justin Tomlinson

    Pension Wise provides free and impartial guidance to those aged 50 and over with a defined contribution pension to help them understand their options.

    It was announced at the 2015 summer budget that the age for eligibility would be lowered to 50. Pension Wise has developed new content for 50 – 54 year olds to make the guidance appointments more relevant to their needs and this is now live.

    The government plans to restructure the delivery of public financial guidance to ensure that all consumers can access the help they need when they need it.

    Pension Wise does not give specific advice on products or provider recommendations. There are currently no plans for Pension Wise to provide guidance on lifetime ISAs or Automatic Enrolment.

  • John Redwood – 2016 Parliamentary Question to the Northern Ireland Office

    John Redwood – 2016 Parliamentary Question to the Northern Ireland Office

    The below Parliamentary question was asked by John Redwood on 2016-06-20.

    To ask the Secretary of State for Northern Ireland, which EU (a) legislative and (b) other proposals her Department is leading negotiations on for the Government in the Council of the EU.

    Mr Ben Wallace

    The Department is not responsible for leading any negotiations at the EU Council.

  • Lord Freyberg – 2016 Parliamentary Question to the Department of Health

    Lord Freyberg – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Freyberg on 2016-09-05.

    To ask Her Majesty’s Government what measures they intend to put in place to ensure that patients with radioiodine refractory differentiated thyroid cancer can receive all effective clinical treatments currently available through EU authorisation.

    Lord Prior of Brampton

    Changes to the process for evaluating cancer drugs were introduced at the end of July 2016 as part of the new arrangements for the Cancer Drugs Fund (CDF). Under the new arrangements, all new cancer drugs are expected to be referred to the National Institute for Health and Care Excellence (NICE) for evaluation through its technology appraisal programme. In some cases, NICE will recommend that the cancer drug is funded through the CDF, which enables further evaluation of its place in therapy. Drugs that have a European Union (EU) or United Kingdom marketing authorisation for radioiodine refractory differentiated thyroid cancer will therefore be reviewed under this process and if found to be clinically and cost effective will become established treatment within the National Health Service.

    The UK remains a member of the EU until Article 50 negotiations have concluded. EU law continues to apply and ongoing compliance with EU law is considered important in facilitating orderly transition, for negotiating purposes, and to offer certainty in the meantime. As long as the UK is subject to EU law, the present arrangements remain in place.

  • Henry Bellingham – 2016 Parliamentary Question to the Ministry of Defence

    Henry Bellingham – 2016 Parliamentary Question to the Ministry of Defence

    The below Parliamentary question was asked by Henry Bellingham on 2016-10-20.

    To ask the Secretary of State for Defence, how much the Iraq Historical Allegations Team have spent on the contract with Red Snapper Recruitment to date.

    Mike Penning

    As of 24 October 2016, the total amount paid to the Red Snapper Group for the contract with the Iraq Historic Allegations Team was £20.8 million including VAT.

  • Carolyn Harris – 2015 Parliamentary Question to the Attorney General

    Carolyn Harris – 2015 Parliamentary Question to the Attorney General

    The below Parliamentary question was asked by Carolyn Harris on 2015-11-23.

    To ask the Attorney General, what recent steps the Crown Prosecution Service has taken to improve the conviction rate for rape and domestic violence.

    Robert Buckland

    The CPS has taken a number of steps to improve the conviction rate for rape and domestic violence cases. These include refocusing resources to strengthen Rape and Serious Sexual Offences Units, extensive training on rape for prosecutors, an update of the domestic abuse legal guidance and closer working with the police in rape cases including the provision of early investigative advice.

  • Karin Smyth – 2016 Parliamentary Question to the Department of Health

    Karin Smyth – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Karin Smyth on 2016-01-04.

    To ask the Secretary of State for Health, when his Department plans to make a decision on whether to refer for consideration by NICE PRRNT treatment for pancreatic cancers.

    George Freeman

    The National Institute for Health and Care Excellence (NICE) has recently consulted stakeholders on the suitability of Lutetium-177 Dotatate – a type of peptide receptor radionuclide therapy (PRRT) – for treating unresectable, somatostatin receptor-positive gastroentero-pancreatic neuroendocrine tumours without disease progression for referral to its technology appraisal work programme. A decision on its referral to NICE will be taken shortly.

  • Andrew Rosindell – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Andrew Rosindell – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Andrew Rosindell on 2016-01-25.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, what discussions he has had with his Spanish counterpart on recent illegal entry into Gibraltarean waters by Spanish vessels.

    Mr David Lidington

    The Government continues to make diplomatic protests to Spain with respect to all incursions into British Gibraltar Territorial Waters (BGTW). Since the agreement of August 2015 to prioritise safety at sea and to step up law enforcement cooperation, there have been fewer incursions that have raised safety concerns and work on improving cooperation between law enforcement agencies is ongoing. Neither I nor the Secretary of State for Foreign and Commonwealth Affairs, my right hon. Friend, the Member for Runnymede and Weybridge (Mr Hammond ), have therefore had cause to raise incursions into BGTW with our Spanish counterparts since my response to Written Question 11709 on 22 October 2015.

  • David Davis – 2016 Parliamentary Question to the Ministry of Defence

    David Davis – 2016 Parliamentary Question to the Ministry of Defence

    The below Parliamentary question was asked by David Davis on 2016-02-22.

    To ask the Secretary of State for Defence, what assessment his Department made of the legality of US airstrikes in Libya before authorising use of RAF Lakenheath for airstrikes in Libya on 19 February 2016.

    Michael Fallon

    I confirmed in a statement on 19 February 2016 that I had authorised the request. Permission was granted once I was satisfied with the legality of the operation.